TY  - JOUR
AU  - Lacroix, Jeannine Ariane Desiree
AU  - Schlund, Franziska
AU  - Leuchs, Barbara
AU  - Adolph, Kathrin
AU  - Sturm, Dominik
AU  - Bender, Sebastian
AU  - Hielscher, Thomas
AU  - Pfister, Stefan
AU  - Witt, Olaf
AU  - Rommelaere, Jean
AU  - Schlehofer, Jörg R
AU  - Witt, Hendrik
TI  - Oncolytic effects of parvovirus H-1 in medulloblastoma are associated with repression of master regulators of early neurogenesis.
JO  - International journal of cancer
VL  - 134
IS  - 3
SN  - 0020-7136
CY  - Bognor Regis
PB  - Wiley-Liss
M1  - DKFZ-2017-03902
SP  - 703 - 716
PY  - 2014
AB  - Based on extensive pre-clinical studies, the oncolytic parvovirus H-1 (H-1PV) is currently applied to patients with recurrent glioblastoma in a phase I/IIa clinical trial (ParvOryx01, NCT01301430). Cure rates of about 40
LB  - PUB:(DE-HGF)16
C6  - pmid:23852775
C2  - pmc:PMC4232887
DO  - DOI:10.1002/ijc.28386
UR  - https://inrepo02.dkfz.de/record/127880
ER  -